Cardiovascular
IMG_2022-9-1-123105.jpg
CardiovascularTAVR to Thrive but Headwinds are Wreaking Havoc on the SpaceTAVR to Thrive but Headwinds are Wreaking Havoc on the Space
JenaValve’s recent financing shows that COVID-related headwinds can’t stop the rapidly evolving TAVR market.
Sign up for the QMED & MD+DI Daily newsletter.